- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2006
- Public Summary Document (PSD) November 2006 PBAC Meeting - PDF
Natalizumab – November 2006
Natalizumab, concentrated solution for IV infusion, 300 mg per 15 mL, Tysabri November 2006
Last updated
16 March 2007